Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 250 movers: Big Yellow surges on possible Blackstone bid; Oxford Instruments tumbles
(Sharecast News) - London's FTSE 250 was up 0.9% at 21,996.29 in afternoon trade on Monday. Big Yellow Group surged after private equity firm Blackstone confirmed it is considering a possible offer for the self-storage company.
In a brief statement in response to recent press speculation, Blackstone said that one or more of the investment funds it advises is considering an offer.
"Blackstone Funds' evaluation of Big Yellow is at a preliminary stage and Blackstone is considering, amongst other factors, the macro-economic environment including the potential impact of the upcoming UK budget as it relates to the self-storage sector," it said.
In a separate statement, Big Yellow confirmed that it has held meetings with a small number of parties in relation to a range of potential options including a potential sale.
"The company is not in receipt of an approach and is not in discussions with any parties in respect of a potential sale of the company at the time of this announcement," it said.
IP Group was also sharply higher after saying it was "encouraged" by the results of a recent clinical trial of a Metsara obesity drug, which could result in future sustainable royalties if approved by regulators.
The company, which invests in early stage businesses in the deeptech, life sciences and cleantech sectors, owns and exclusively licenses certain underlying IP relating to Metsera's programmes including its lead product MET-097i, a monthly injectable GLP-1 drug.
Gold miners Endeavour and Hochschild shone as gold prices rose.
Oxford Instruments tumbled after it confirmed a fall in first-half revenues, saying it had been hit hard by US tariffs.
FTSE 250 - Risers
Big Yellow Group (BYG) 1,140.00p 18.13% IP Group (IPO) 59.90p 12.81% Endeavour Mining (EDV) 3,440.00p 11.40% Safestore Holdings (SAFE) 716.50p 9.47% Hochschild Mining (HOC) 388.80p 7.28% Aston Martin Lagonda Global Holdings (AML) 63.65p 6.71% Great Portland Estates (GPE) 329.50p 4.60% Vistry Group (VTY) 626.60p 3.67% Fidelity China Special Situations (FCSS) 326.00p 3.66% Future (FUTR) 649.00p 3.34%
FTSE 250 - Fallers
Oxford Instruments (OXIG) 1,824.00p -7.88% Oxford Nanopore Technologies (ONT) 143.00p -2.46% QinetiQ Group (QQ.) 491.00p -1.76% Edinburgh Worldwide Inv Trust (EWI) 203.00p -1.46% Helios Towers (HTWS) 145.60p -1.36% Edinburgh Inv Trust (EDIN) 808.00p -1.34% Baillie Gifford US Growth Trust (USA) 263.50p -1.31% Ithaca Energy (ITH) 187.70p -1.21% Worldwide Healthcare Trust (WWH) 342.00p -1.16% JPMorgan Global Growth & Income (JGGI) 561.00p -1.06%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
